Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenue to date.
Drugs Made In America Acquisition II Corp의 주요 재무제표는 무엇인가요?
최신 재무제표(Form-10K)에 따르면, Drugs Made In America Acquisition II Corp의 총 자산은 $0이며, 순손실입니다.
DMIIU의 주요 재무 비율은 무엇인가요?
Drugs Made In America Acquisition II Corp의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Drugs Made In America Acquisition II Corp의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Drugs Made In America Acquisition II Corp 주요 수익원은 Banking and Related Activities이며, 최신 수익 발표에서 수익은 18,735,887입니다. 지역별로는 United States이 Drugs Made In America Acquisition II Corp의 주요 시장이며, 수익은 18,735,887입니다.
Drugs Made In America Acquisition II Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Drugs Made In America Acquisition II Corp의 순손실은 $0입니다.
Drugs Made In America Acquisition II Corp에 부채가 있나요?
no, Drugs Made In America Acquisition II Corp의 부채는 0입니다.
Drugs Made In America Acquisition II Corp의 발행 주식은 몇 주인가요?
Drugs Made In America Acquisition II Corp의 총 발행 주식은 0주입니다.